Direct detection and characterisation of infectious agents (B3) – in addition to Rili-BÄK
Bacteria
Investigation
EQA scheme
Program 25 (pages)
Program 26 (pages)
-
B-streptococcus screening
-
Carbapenemase detection (4MRGNs)
-
Detection of bacteria in platelet concentrates
-
Legionella pneumophila antigen in urine
-
Molecular biological detection of carbapenemases
-
MRGN screening (Germ identification, resistance status)
-
MRSA screening for cultural detection and NAT methods
-
Mycoplasma genitalium, genome detection
-
Mycoplasma hominis, genome detection
-
Panton-Valentine leukocidin (PVL) detection
-
Ribotype 027 detection
-
Streptococcus pneumoniae antigen in urine
-
Trichomonas vaginalis, genome detection
-
Vancomycin-resistant enterococci (VRE), cultural detection
-
Vancomycin-resistant enterococci (VRE), molecular biological detection VanA, VanB, and others
Viruses
Investigation
EQA scheme
Program 25 (pages)
Program 26 (pages)
-
SARS-CoV-2 antigen
Blood culture medium
Investigation
EQA scheme
Program 25 (pages)
Program 26 (pages)
-
Bloodstream infection detection (multiplex)